Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
BMC Geriatrics|February 26, 2024
Assessing frailty amongst older people admitted to hospital in a low-income setting: a multicentre study in northern TanzaniaSean L Davidson, Luke Emmence, Sara May Motraghi-Nobes, et al.
BMJ Open|September 30, 2020
Study protocol for the COPE study: COVID-19 in Older PEople: the influence of frailty and multimorbidity on survival. A multicentre, European observational studyAngeline Price, Fenella Barlow-Pay, Siobhan Duffy, et al.
Journal of Psychopharmacology (Oxford, England)|October 26, 2020
The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signallingKinga Sałaciak, Monika Głuch-Lutwin, Agata Siwek, et al.
Parkinsonism & Related Disorders|August 19, 2015
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine releaseMattia Volta, Stefano Cataldi, Dayne Beccano-Kelly, et al.
Elife|September 21, 2017
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceMattia Volta, Dayne A Beccano-Kelly, Sarah A Paschall, et al.
Human Molecular Genetics|October 26, 2014
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memoryDayne A Beccano-Kelly, Mattia Volta, Lise N Munsie, et al.
Nature Communications|May 14, 2016
Behavioural traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanismsEmma Mitchell, Shifra L Klein, Kimon V Argyropoulos, et al.
International Journal of Cardiology. Heart & Vasculature|October 21, 2020
The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19Philip Braude, Ben Carter, Roxanna Short, et al.
The Lancet. Public Health|July 4, 2020
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort studyJonathan Hewitt, Ben Carter, Arturo Vilches-Moraga, et al.
Therapeutic Advances in Drug Safety|March 8, 2021
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19Phyo K Myint, Ben Carter, Fenella Barlow-Pay, et al.
Pageof 5